Harmony Biosciences Holdings, Inc.
HRMY
$31.43
$0.491.58%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 28.71% | 16.01% | 19.48% | 19.51% | 16.08% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 28.71% | 16.01% | 19.48% | 19.51% | 16.08% |
| Cost of Revenue | 39.44% | 18.69% | 16.41% | 26.09% | 32.46% |
| Gross Profit | 25.51% | 15.40% | 20.14% | 17.24% | 11.95% |
| SG&A Expenses | 5.69% | 14.83% | 17.10% | 3.12% | 22.19% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 39.93% | 0.56% | 25.25% | 13.51% | 29.83% |
| Operating Income | 6.12% | 125.60% | 8.09% | 38.64% | -4.34% |
| Income Before Tax | 8.56% | 128.81% | 10.41% | 41.49% | 19.95% |
| Income Tax Expenses | 3.41% | -2.40% | -13.63% | -48.94% | 20.24% |
| Earnings from Continuing Operations | 10.35% | 243.16% | 18.85% | 85.95% | 19.84% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 10.35% | 243.16% | 18.85% | 85.95% | 19.84% |
| EBIT | 6.12% | 125.60% | 8.09% | 38.64% | -4.34% |
| EBITDA | 5.58% | 97.56% | 6.97% | 33.19% | -4.16% |
| EPS Basic | 9.04% | 239.10% | 17.74% | 89.94% | 26.15% |
| Normalized Basic EPS | 7.27% | 126.14% | 9.38% | 44.53% | 6.24% |
| EPS Diluted | 10.13% | 240.00% | 16.42% | 89.84% | 25.40% |
| Normalized Diluted EPS | 7.43% | 125.38% | 8.67% | 43.04% | 5.41% |
| Average Basic Shares Outstanding | 1.20% | 1.17% | 0.95% | -2.10% | -5.00% |
| Average Diluted Shares Outstanding | 1.06% | 1.54% | 1.61% | -1.08% | -4.25% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |